Actively Recruiting
Advantages of Early Intrauterine Transfer of "Blank" Culture Medium Prior to 1st or 2nd Transfer of Thawed Embryo(s).
Led by Centre Hospitalier Universitaire de Nīmes · Updated on 2025-02-20
1154
Participants Needed
7
Research Sites
155 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Despite technical advances in Medically Assisted Reproduction (AMP), the success of fertility treatments is sometimes limited by embryo implantation failure. The coordinated development of the embryo and the uterine endometrium requires close communication between the maternal tissue and the embryo. In in vitro fertilization (IVF), embryo transfer generally takes place between the 2nd (D2) and the 6th (D6) day following oocyte fertilization. Recent studies have shown the advantages of sequential transfer (transfer of an embryo on D2/D3 followed by the transfer of another embryo on D5/D6), with higher implantation and clinical pregnancy rate, fewer miscarriages, more live births, and yet no increase in multiple pregnancies. However, the American Society for Reproductive Medicine recommendations continue to prioritize the transfer of a single embryo for all patients aged under 38. To improve pregnancy rates for patients having a single embryo transferred, the study investigators wish to carry out on "blank" transfer, based on the principle of sequential transfer. The study investigators hypothesize that a culture medium, placed in the uterus before the time of embryo transfer, will modify immune tolerance. The study will test whether transferring the same culture medium in an equivalent quantity as during the real transfer into the uterus 2/3 days before the embryo transfer will improve tolerance to this foreign medium and, therefore, embryo implantation. The aim of this study is thus to evaluate the impact of a "blank" transfer with culture medium alone, on the results of frozen embryo transfers (FET) from IVF.
CONDITIONS
Official Title
Advantages of Early Intrauterine Transfer of "Blank" Culture Medium Prior to 1st or 2nd Transfer of Thawed Embryo(s).
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Had a first fresh or frozen embryo transfer followed by pregnancy failure
- Frozen embryos must be at least at day 3 stage
- Provided free and informed consent and signed the consent form
- Member or beneficiary of a health insurance plan
You will not qualify if you...
- Currently participating in an interventional study or within an exclusion period from a previous study
- Under safeguard of justice or state guardianship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Hôpital Antoine Béclère
Clamart, France
Not Yet Recruiting
2
Centre Hospitalier Alpes Léman
Contamine-sur-Arve, France
Not Yet Recruiting
3
CHU Arnaud de Villeneuve
Montpellier, France
Not Yet Recruiting
4
Clinique Saint Roch
Montpellier, France
Not Yet Recruiting
5
CHU de Nîmes
Nîmes, France, 30029
Actively Recruiting
6
Clinique Saint-Pierre
Perpignan, France
Not Yet Recruiting
7
CHU de la Réunion
Saint-Pierre, Reunion
Not Yet Recruiting
Research Team
N
Nathalie Rougier
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here